Yousef Tizabi

Howard University 
Pharmacology, Neuroscience Biology
"Yousef Tizabi"
Mean distance: 13358.2
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tizabi Y, Getachew B, Csoka AB, et al. (2019) Novel targets for parkinsonism-depression comorbidity. Progress in Molecular Biology and Translational Science. 167: 1-24
Getachew B, Tizabi Y. (2019) Antidepressant Effects of Moxidectin, an Antiparasitic Drug, in a Rat Model of Depression. Behavioural Brain Research. 112220
Parra I, Martínez I, Ramírez-García G, et al. (2019) Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease. Neurotoxicity Research
Getachew B, Reyes RE, Davies DL, et al. (2019) Moxidectin Effects on Gut Microbiota of Wistar-Kyoto Rats: Relevance to Depressive-Like Behavior. Clinical Pharmacology and Translational Medicine. 3: 134-142
Getachew B, Mendieta L, Csoka AB, et al. (2019) Antidepressant Effects of C-Terminal Domain of the Heavy Chain of Tetanus Toxin in a Rat Model of Depression. Behavioural Brain Research. 111968
Getachew B, Tizabi Y. (2019) Both Ketamine and NBQX Attenuate Alcohol-Withdrawal Induced Depression in Male Rats. Journal of Drug and Alcohol Research. 8
Reglodi D, Toth D, Vicena V, et al. (2019) Therapeutic potential of PACAP in alcohol toxicity. Neurochemistry International
Patricio F, Parra I, Martínez I, et al. (2019) Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson's Disease. Neurotoxicity Research
Getachew B, Aubee JI, Schottenfeld RS, et al. (2018) Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties. Bmc Microbiology. 18: 222
Getachew B, Csoka AB, Aschner M, et al. (2018) Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson's disease. Neurochemistry International. 124: 19-24
See more...